DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 13F Portfolio
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) runs DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) and currently holds 82 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $9.59B. Their top holdings are NUVL, RVMD, PRAX, VTRS, CNC. The top five represent 36.9% of reported portfolio weight. DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) initiated 7 new positions. They added to 13 existing positions. They trimmed 10 positions. Their current best-performing preview position is HUM with returns of +129.09%.
Portfolio Value
$9.59B
Alpha Score
73.1
#0 of 1000
Holdings
82
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Current 13F Holdings
Reported holdings from DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s latest SEC 13F filing, ranked by portfolio weight.
82 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 NUVL NUVALENT INC | 22.22% | $22.79 | $123.96 | +443.92% | Held |
 RVMD REVOLUTION MEDICINES INC | 4.67% | $35.80 | $189.76 | +430.06% | Added +4.14% |
 PRAX PRAXIS PRECISION MEDICINES I | 3.36% | $74.95 | $259.86 | +246.71% | Held |
 VTRS VIATRIS INC | 3.35% | $13.31 | $17.64 | +32.53% | Held |
 CNC CENTENE CORP DEL | 3.28% | $46.05 | $65.36 | +41.92% | Trimmed -17.17% |
 UTHR UNITED THERAPEUTICS CORP DEL | 2.58% | $318.01 | $549.16 | +72.69% | Held |
 LEGN LEGEND BIOTECH CORP | 2.45% | $25.75 | $18.62 | -27.69% | Added +5.85% |
 COGT COGENT BIOSCIENCES INC | 2.02% | $12.76 | $31.00 | +142.95% | Trimmed -44.65% |
 GMAB GENMAB A/S | 1.97% | $27.24 | $37.07 | +36.09% | Added +178.84% |
 BKD BROOKDALE SR LIVING INC | 1.95% | $4.47 | $10.12 | +126.40% | Held |
Showing 1-10 of 82